Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors

Clinical trial NCT05699915 · TERMINATED

Trial details

NCT number: NCT05699915
Sponsor: Algemeen Ziekenhuis Maria Middelares
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Cancer Immune-related Adverse Event Cardiac Abnormalities, Variable Immune Checkpoint Inhibitor-Related Myocarditis Diastolic Dysfunction Atherosclerosis Cardiotoxicity

Start date: 2022-01-07
Primary completion: 2024-07-12
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.